Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factors
暂无分享,去创建一个
[1] J. Vilček,et al. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. , 1987, The Journal of biological chemistry.
[2] R. Taub,et al. Insulin as a growth factor in rat hepatoma cells. Stimulation of proto-oncogene expression. , 1987, The Journal of biological chemistry.
[3] Bruce M. Spiegelman,et al. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos , 1987, Cell.
[4] D. Bowtell,et al. Murine c-myc retroviruses alter the growth requirements of myeloid cell lines. , 1987, Oncogene research.
[5] A. Kinniburgh,et al. Relatively stable population of c-myc RNA that lacks long poly(A) , 1987, Molecular and cellular biology.
[6] E. Rozengurt,et al. Bombesin induction of c‐fos and c‐myc proto‐oncogenes in Swiss 3T3 cells: Significance for the mitogenic response , 1987, Journal of cellular physiology.
[7] B. Cochran,et al. Inducible binding of a factor to the c-fos regulatory region. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Mccaffrey,et al. Two independent growth factor-generated signals regulate c-fos and c-myc mRNA levels in Swiss 3T3 cells. , 1987, The Journal of biological chemistry.
[9] K. Nishikura,et al. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. , 1987, Molecular and cellular biology.
[10] B. Calabretta. Dissociation of c-fos induction from macrophage differentiation in human myeloid leukemic cell lines , 1987, Molecular and cellular biology.
[11] R. Roeder,et al. Inducible binding of a factor to the c-fos enhancer , 1986, Cell.
[12] R. Weinberg,et al. Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression , 1986, Molecular and cellular biology.
[13] V. Sorrentino,et al. Potentiation of growth factor activity by exogenous c-myc expression. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Campisi,et al. Induction of c-fos and c-myc mRNA by epidermal growth factor or calcium ionophore is cAMP dependent. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. P. Studzinski,et al. Participation of c-myc protein in DNA synthesis of human cells. , 1986, Science.
[16] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[17] Richard Treisman,et al. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors , 1986, Cell.
[18] G. Colletta,et al. Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture. , 1986, Science.
[19] G. Sonenshein,et al. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. , 1986, The Journal of biological chemistry.
[20] A. Nienhuis,et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Vallee,et al. A microtubule-activated ATPase from sea urchin eggs, distinct from cytoplasmic dynein and kinesin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] I. Verma,et al. Proto-oncogene expression in regenerating liver is simulated in cultures of primary adult rat hepatocytes. , 1986, The Journal of biological chemistry.
[23] Mark Groudine,et al. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.
[24] P. Nowell,et al. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Mitchell,et al. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages , 1986, Cell.
[26] T. Curran,et al. Expression of c‐fos in NIH3T3 cells is very low but inducible throughout the cell cycle. , 1986, The EMBO journal.
[27] R. Steinman,et al. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A , 1986, The Journal of experimental medicine.
[28] A. Moses,et al. Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells. , 1986, The Journal of biological chemistry.
[29] B. Beutler,et al. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Sporn,et al. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor , 1986, Molecular and cellular biology.
[31] J. Campisi,et al. c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest , 1986, Molecular and cellular biology.
[32] B. Verrier,et al. Interleukin‐3‐dependent expression of the c‐myc and c‐fos proto‐oncogenes in hemopoietic cell lines. , 1986, The EMBO journal.
[33] M. Cole,et al. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes , 1986, Molecular and cellular biology.
[34] M. Groudine,et al. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. , 1985, Science.
[35] I. Verma,et al. Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. , 1985, Science.
[36] T. Rabbitts,et al. Truncation of exon 1 from the c‐myc gene results in prolonged c‐myc mRNa stability. , 1985, The EMBO journal.
[37] C. Stiles,et al. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells , 1985, Cell.
[38] G. Lenoir,et al. Aberrant c‐myc RNAs of Burkitt's lymphoma cells have longer half‐lives. , 1985, The EMBO journal.
[39] M. Greenberg,et al. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. , 1985, The Journal of biological chemistry.
[40] S. Coughlin,et al. c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF , 1985, Cell.
[41] C. Dani,et al. c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors , 1985, Nature.
[42] J. Cleveland,et al. Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes , 1985, Nature.
[43] Richard Treisman,et al. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences , 1985, Cell.
[44] J. Blanchard,et al. Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors , 1985, Cell.
[45] E. Smeland,et al. The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Evan,et al. Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. , 1985, EMBO Journal.
[47] C. Dani,et al. Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[48] L. Kaczmarek,et al. Microinjected c-myc as a competence factor. , 1985, Science.
[49] W. Leonard,et al. Sequential expression of genes involved in human T lymphocyte growth and differentiation , 1985, The Journal of experimental medicine.
[50] T. Curran,et al. Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c‐fos and c‐myc proto‐oncogenes. , 1985, The EMBO journal.
[51] E. Antón,et al. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[52] P. Golstein,et al. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester , 1985, Nature.
[53] T. Graf,et al. Transformation of mammalian fibroblasts and macrophages in vitro by a murine retrovirus encoding an avian v‐myc oncogene. , 1984, The EMBO journal.
[54] I. Verma,et al. Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor. , 1984, Science.
[55] Michael J. Berridge,et al. Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.
[56] C. Dani,et al. Extreme instability of myc mRNA in normal and transformed human cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[57] Michael E. Greenberg,et al. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene , 1984, Nature.
[58] L. Lemieux,et al. Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[59] P. Leder,et al. Functional role for c-myc in mitogenic response to platelet-derived growth factor , 1984, Nature.
[60] T. Sugimura,et al. C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment , 1984, Nature.
[61] M. Cole,et al. Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: Similar RNA levels in tumor and proliferating normal cells , 1984, Cell.
[62] Y. Nishizuka. The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.
[63] H. E. Gray,et al. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation , 1984, Cell.
[64] P. Leder,et al. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.
[65] Brent H. Cochran,et al. Molecular cloning of gene sequences regulated by platelet-derived growth factor , 1983, Cell.
[66] R. Ross,et al. Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. , 1981, The Journal of biological chemistry.
[67] J. Smith,et al. Cytoplasmic transfer of the mitogenic response to platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[68] C. Stiles,et al. Dual control of cell growth by somatomedins and platelet-derived growth factor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[69] C. Stiles,et al. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[70] R. Michell. Inositol phospholipids and cell surface receptor function. , 1975, Biochimica et biophysica acta.
[71] Eric Wickstrom,et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.
[72] John Koontzll. Insulin as a Growth Factor in Rat Hepatoma Cells , 1987 .
[73] M. Groudine,et al. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle , 1985, Nature.
[74] Jonathan A. Cooper,et al. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein , 1984, Nature.
[75] T. Curran,et al. Induction of c-fos gene and protein by growth factors precedes activation of c-myc , 1984, Nature.
[76] John P. Moore,et al. Mitogens increase phosphorylation of phosphoinositides in thymocytes , 1984, Nature.